QA: Altrazeal Life Sciences Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001168220_2016_Altrazeal_Life_Sciences_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001168220, Altrazeal Life Sciences Inc

  xvar xval
0 AssetsCurrent 926,805
1 IntangibleAssetsNetIncludingGoodwill 2,720,541
2 PropertyPlantAndEquipmentNet 257,417
3 remainder_Assets 3,524,304
4 LiabilitiesCurrent 2,540,403
5 LiabilitiesNoncurrent 685,287
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,695,794
9 ResearchAndDevelopmentExpense 764,249
10 remainder_Expenses 1,111,122
11 remainder_Revenues 932,958
12 remainder_NetIncome 1,067,063
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 7,429,067
1 Liabilities 3,225,690
2 Expenses 3,571,165
3 Revenues 932,958
4 StockholdersEquity 4,203,377
5 NetIncome -1,571,144
6 ComprehensiveNetIncome -1,571,144
7 BaseVar 8,112,972
8 EconomicCapitalRatiobeforeLimitedLiability 1.43
9 EconomicCapitalRatio 2.62

Edgar->Model Mapping

Feature Distribution

Change over Time